Table 4 Clinicopathological characteristics of PDAC patients from TCGA
From: The expression and survival significance of sodium glucose transporters in pancreatic cancer
Features | No. of all patients (%) |
|---|---|
Age (years) | 144 (100) |
 <66 | 73 (50.7) |
 ≥ 66 | 71 (49.3) |
Gender | 144 (100) |
 Female | 68 (47.2) |
 Male | 76 (52.8) |
T stage | 144 (100) |
 T1 | 4 (2.8) |
 T2 | 15 (10.4) |
 T3 | 122 (84.7) |
 T4 | 3 (2.1) |
N stage | 143 (100) |
 N0 | 36 (25.2) |
 N1 | 107 (74.8) |
TNM Stage | 144 (100) |
 I | 12 (8.3) |
 II | 126 (87.5) |
 III | 3 (2.1) |
 IV | 3 (2.1) |
Grade | 144 (100) |
 G1 | 20 (13.9) |
 G2 | 82 (56.9) |
 G3 | 41 (28.5) |
 G4 | 1 (0.7) |
Surgery type | 142 (100) |
 Distal Pancreatectomy | 15 (10.6) |
 Whipple | 115 (81.0) |
 Total Pancreatectomy | 1 (0.7) |
 Other type | 11 (7.7) |
Residual tomour | 133 (100) |
 R0 | 82 (61.7) |
 R1 | 46 (34.6) |
 R2 | 5 (3.7) |
History of diabetes | 119 (100) |
 No | 86 (72.3) |
 Yes | 33 (27.7) |